Electrophysiologic and morphologic abnormalities in the failing heart: Effect of enalapril on the electrical properties

Journal of Cardiac Failure

Volumn 3, Issue 1, 1997, Pages 53-61

  De Mello, Walmor C ^a   Cherry, Rebecca C ^a   Manivannan, S ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Changes; Electrophysiologic; Enalapril; Heart failure

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ACTION POTENTIAL; ANIMAL; ARTICLE; DRUG EFFECT; ELECTROPHYSIOLOGY; FORWARD HEART FAILURE; HAMSTER; HEART; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE; HEART VENTRICLE FUNCTION; MALE; NERVE CONDUCTION; PATHOLOGY; PATHOPHYSIOLOGY;

ACTION POTENTIALS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARDIAC OUTPUT, LOW; CRICETINAE; ELECTROPHYSIOLOGY; ENALAPRIL; HEART; HEART CONDUCTION SYSTEM; HEART VENTRICLES; MALE; NEURAL CONDUCTION; VENTRICULAR FUNCTION;

EID: 0031089620     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(97)90008-7     Document Type: Article

References (46)

1. Kowey PR, Friehling TD, Sewter J, Wu Y, Sokil A, Paul J, Nocella J: Electrophysiological effects of left ventricular hypertrophy: effect of calcium and potassium channel blockade. Circulation 1991;83:2067-75
2. Kowey PR, O'Brien R, Wu Y, Sewter J, Sokjil A, Nocella J, Rials SJ: Effect of gallopamil on electrophysiologic abnormalities and ventricular hypertrophy in the feline heart. Am Heart J 1992;124:898-905
3. Shechter JA, O'Conner ICM, Friehling TD, Mark R, Uboh C, Kowey PR: Electrophysiologic effects of left ventricular hypertrophy in the intact cat. Am J Hypertension 1989; 2:81-5
4. Charpentier F, Baudet S, Le Maree II: Triggered activity as a possible mechanism for arrhythmias in ventricular hypertrophy. PACE Pacing Clin Electrophysiol 1991;14: 1735-41
5. Aronson RS: Afterpotentials and triggered activity in hypertrophied myocardium from rats with renal hypertension. Circ Res 1981;48:720-7
6. Ben-David J, Zipes DP, Ayers GM, Pride HP: Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early after depolarizations after administration of BAY K 8644. J Am Coll Cardiol 1992;20:1576-84
7. Taylor AI, Winter R, Thandroyen I, Murphree S, Buja LM, Eckels R, Pastor P, Kremers M: Potentiation of reperfusion-associated ventricular fibrillation by left ventricular hypertrophy. Circ Res 1990;67:501-9
8. Aronson RS: Characteristics of action potentials of hypertrophied myocardium from rats with renal hypertension. Circ Res 1980;47:443-54
9. Rials SJ, Wu Y, Ford N, Pauletto FJ, Abramson SV, Rubin A, Marinchak RA, Kowey PR: Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation 1995;91:426-30
10. Bajusz E: Dystrophic calcification of myocardium as conditioning factor in genesis of congestive heart failure: an experimental study. Am Heart J 1969;78:202-9
11. Gertz EW: Cardiomyopathic Syrian hamster: a possible model of human disease. Prog Exp Tumor Res 1992; 16:242-7
12. Jasmin G, EU HY: Cardiomyopathy of hamster distrophy. Ann NY Acad Sci 1979;317:46-58
13. Baker KM, Chermin MI, Wixson SK, Aceto JF: Renin angiotensin system involvement in pressure overload cardiac hypertrophy in rats. Am J Physiol 1990;259:H324-32
14. Dzau VJ: Cardiac renin-angiotensin system. Am J Med 1988;84:22-7
15. Rogers TB, Gaa AH, Allen TS: Identification and characterization of functional angiotensin II receptors on cultured heart myocytes. J Pharmacol Exp Ther 1986;36: 438-44
16. Linz W, Scholkens BA, Han JF. Beneficial effects of the converting enzyme inhibitor ramipril in ischemic rat heart. J Cardiovasc Pharmacol 1986;8(suppl 10):S91-9
17. Field LJ, McGowan RA, Dickinson DP, Gross KW: Tissue and gene specificity of mouse renin expression. Hypertension 1984;6:597-603
18. Ohkubo H, Nakayama K, Tamaka T, Nakanishi S: Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. J Biol Chem 1986;261: 319-73
19. Dzau VJ, Ingelfinger J, Pratt RE, Ellison KE: Identification of renin and angiotensinogen RNA sequences in mouse and rat brains. Hypertension 1986;8:544-8
20. De Mello WC, Altieri P. The role of the renin-angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II. J Cardiovasc Pharmacol 1992;20:643-51
21. De Mello WC: Is an intracellular renin-angiotensin system involved in the control of cell communication in heart? J Cardiovasc Pharmacol 1994;23:640-6
22. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau V: Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991; 69:475-82
23. Sakata Y: Tissue factors contributing to cardiac hypertrophy in cardiomyopathic hamsters: involvement of transforming-growth factor beta-1 and tissue renin-angiotensin system in the progression of cardiac hypertrophy. Hokkaido Igaku Zasshi 1993;68(1):18-28
24. De Mello WC, Manivannan S: Electrophysiology of the failing heart: effect of enalapril. FASEB J 1995;9:A-604
25. Brooks CMC, Hoffman BF, Suckling EE, Orias O: Excitability of the heart. Grune and Straton, New York, 1955
26. Hoffman BF, Cranefield PF: Electrophysiology of the heart. McGraw-Hill, New York, 1960
27. Beltrami CA, Finato N, Rocco M, Feruglio GA: The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 1995;27:291-305
28. Grima M, Welsch C, Michel B, Barthelkmebs M, Imbs YL: In vitro tissue potencies of converting enzyme inhibitors. Hypertension 1991;17:492-6
29. De Mello WC, Crespo MJ, Altieri P: Enalapril increases cardiac refractoriness. J Cardiovasc Pharmacol 1992;20: 820-5
30. Rossner K, Sachs HG: Electrophysiological study of Syrian hamster hereditary cardiomyopathy. Cardiovasc Res 1978;12:436-43
31. Jasmin G, Proschek L: Calcium and myocardial cell injury: an appraisal in the cardiomyopathic hamster. Can J Physiol Pharmacol 1984;62:891-8
32. Ferrans VJ, Buja LM, Maron BJ: Myofibrillar abnormalities following cardiac muscle cell injury. In Flickenstein A and Rona G: Recent advances in studies on cardiac structure and metabolism. Vol 6. Pathophysiology and morphology of myocardial cell alteration. University Park Press, Baltimore, 1975, pp. 367-82
33. Ganote CE: Contraction band necrosis and irreversible myocardial injury. J Mol Cell Cardiol 1983;15:67-73
34. De Mello WC: Renin-angiotensin system and cell communication in the failing heart. Hypertension, 1996;27:265-8
35. Kannel WB, Abbott RD: A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham study. Am Heart J 1986;111:391-7
36. Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED: Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984;77:18-22
37. McLenachan JM, Henderson EM, Morris KI, Dargie HJ: Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987;317: 787-92
38. Weber KT, Janicki JS: Angiotensin and the remodeling of the myocardium. Br J Clin Pharmacol 1989;28:141S-50S
39. Ganten D, Shelling P, Flugel RM, Ganten V: Effect of angiotensin and angiotensin antagonist on iso-renin and cell growth in 3T3 mouse cells. Int Res Comm Med Sci 1975;3:327-32
40. Tan LB, Jalil YE, Janicki YS, Weber KT: Cardiotoxic effects of angiotensin II. J Am Cell Cardiol 1989;13:2A (abstract)
41. 1 pumping in cardiac myocytes. Am J Physiol 1995;268:C366-75
42. De Mello WC: Influence of intracellular renin on heart cell communication. Hypertension 1995;25:1172-77
43. Sen L, O'Neill M, Marsh JD, Smith TW: Myocyte structure, function and calcium kinetics in the cardiomyopathic hamster heart. Am J Physiol 1990;28:H1533-43
44. De Mello WC: Effect of intracellular injection of calcium and strontium on cell communication in heart. J Physiol 1975;250:231-45
45. De Mello WC: Interaction between cyclic AMP and Ca in the control of electrical coupling in heart fibers. Biochem Biophys Acta 1986;888:91-9
46. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1992;316:1429-35